Recent News

• 04.08.2025 - Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 04.08.2025 - Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 03.13.2025 - Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
• 03.13.2025 - Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
• 03.12.2025 - Barclays 27th Annual Global Healthcare Conference
• 03.12.2025 - Barclays 27th Annual Global Healthcare Conference
• 03.11.2025 - Leerink's Global Healthcare Conference 2025
• 03.11.2025 - Leerink's Global Healthcare Conference 2025
• 03.07.2025 - Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 03.07.2025 - Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 03.13.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 03.13.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.13.2025 - 8-K Current report
• 03.13.2025 - EX-99.1 EX-99.1
• 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2025 - 4 Statement of changes in beneficial ownership of securities